Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 12,394 AVTX shares, $122.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 12,394 | $122.5K |
| Sep 11, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 10,185 | $81.9K |
| Aug 19, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 37,945 | $374.9K |
| Jun 12, 2026 | Avalo Therapeutics, Inc. (AVTX) | Tax Withholding | 138 | $1.8K |
| May 26, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 39,900 | n/a |
| May 11, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 18,606 | $183.8K |
| May 7, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 47,000 | $377.9K |
| May 1, 2026 | Avalo Therapeutics, Inc. (AVTX) | Sale | 8,458 | $110.7K |
| Apr 3, 2026 | Avalo Therapeutics, Inc. (AVTX) | Sale | 500 | $7.9K |
| Mar 31, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 24,200 | n/a |